Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.

NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators

TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.

METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help

NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product

COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors

INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Parnell Pharmaceuticals Holdings Ltd. Stock Analysis PARNF
Parnell Pharmaceuticals Holdings Ltd. is a veterinary pharmaceutical company, which engages in the development, manufacture, and commercialization of animal health solutions. The company is headquartered in Mascot, New South Wales. The company went IPO on 2014-06-18. The firm operates sterile manufacturing facilities and offers digital technology platforms that integrate with the Company’s products to offer veterinarians and animal owners superior solutions for their animal health needs. The firm also provides a fully integrated animal health platform. The Company’s mySYNCH is a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. The Company’s products include GONAbreed, estroPLAN, and RESPIRmycin. GONAbreed is used for the treatment of cystic ovaries and used in cattle synchronization protocols. The estroPLAN is used in animals with unobserved or non-detected estrus in cattle undergoing synchronization protocols. The RESPIRmycin is used for the treatment of respiratory disease in beef and non-lactating dairy cattle.
Read More Parnell Pharmaceuticals Holdings Ltd (PARNF) Chart
Key Statistics of Parnell Pharmaceuticals Holdings Ltd (PARNF)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.08Volume
100.00P/E Ratio (TTM)
-52 Week Range
Market Cap
2.23MAvg. Volume
8164.71Dividend Yield
-Financial Metrics & Statements of Parnell Pharmaceuticals Holdings Ltd (PARNF)
FAQ's for Parnell Pharmaceuticals Holdings Ltd (PARNF)
- According to Musaffa’s Shariah screening methodology, Parnell Pharmaceuticals Holdings Ltd (PARNF) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Parnell Pharmaceuticals Holdings Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Parnell Pharmaceuticals Holdings Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Parnell Pharmaceuticals Holdings Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Parnell Pharmaceuticals Holdings Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Parnell Pharmaceuticals Holdings Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.